Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839995 · ClinicalTrials.gov registry record
Use of ROTEM for Multi-level Spine Surgery
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 41
- Enrollment target
NCT00839995: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00839995 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00839995 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain coagulation profiles of patients undergoing multi-level spine surgeries with ROTEM® and routine coagulation tests. The investigators will compare the data from ROTEM® and routine coagulation tests with each other and with blood loss and transfusion therapies used.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-12 |
What the finished NCT00839995 record still lists
NCT00839995 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00839995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00839995 about?
NCT00839995 is a clinical study titled "Use of ROTEM for Multi-level Spine Surgery". The purpose of this study is to obtain coagulation profiles of patients undergoing multi-level spine surgeries with ROTEM® and routine coagulation tests. The investigators will compare the data from ROTEM® and routine coagulation tests with each other and with blood loss and transfusion therapies us...
What is the current status of trial NCT00839995?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2009-02. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00839995?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia